Jefferies initiated coverage on NuVasive with a new price target
$NUVA
Medical/Dental Instruments
Health Care
Jefferies initiated coverage of NuVasive with a rating of Hold and set a new price target of $45.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/10/2023 | $57.72 | Overweight → Equal Weight | Wells Fargo |
| 2/10/2023 | $63.00 → $52.00 | Buy → Neutral | Citigroup |
| 2/10/2023 | $51.00 → $52.50 | Buy → Hold | Truist |
| 1/6/2023 | Buy → Hold | Needham | |
| 10/18/2022 | $53.00 | Overweight | Barclays |
| 10/12/2022 | $45.00 | Hold | Jefferies |
| 4/13/2022 | $60.00 → $65.00 | Buy | Truist |
| 3/28/2022 | $58.00 | Overweight | Wells Fargo |